Activase (alteplase) - Roche, Boehringer Ingelheim, Kyowa Kirin, Tanabe Pharma
Association Between the Geriatric Nutritional Risk Index and All-Cause Mortality in Elderly Patients with Acute Ischemic Stroke After Intravenous Thrombolysis. (PubMed, Int J Gen Med) - Sep 8, 2026 - "This single-center cohort study recruited elderly patients with AIS who received intravenous alteplase thrombolysis, and GNRI was used to evaluate their nutritional status...Additionally, a linear association between GNRI and all-cause mortality was found using RCS (nonlinear p-value = 0.478). This study found that among older patients with AIS, lower levels of GNRI were linked to all-cause mortality following intravenous thrombolysis.The GNRI could potentially be used to predict all-cause mortality; however, further multicenter studies are needed to confirm the generalizability of these findings." 
Journal • Cardiovascular • Ischemic stroke
http://www.ncbi.nlm.nih.gov/pubmed/42703525
 
Feng Tu; Jian Chen; Jinghong Lu; Yu Fu; Zhihong Wang
 
Sep 8, 2026
 
Prev Next